JP4885122B2 - 癌、器官傷害、および筋肉リハビリテーション/運動過剰訓練についての診断の生物マーカーとしてのタンパク質分解マーカー - Google Patents
癌、器官傷害、および筋肉リハビリテーション/運動過剰訓練についての診断の生物マーカーとしてのタンパク質分解マーカー Download PDFInfo
- Publication number
- JP4885122B2 JP4885122B2 JP2007508611A JP2007508611A JP4885122B2 JP 4885122 B2 JP4885122 B2 JP 4885122B2 JP 2007508611 A JP2007508611 A JP 2007508611A JP 2007508611 A JP2007508611 A JP 2007508611A JP 4885122 B2 JP4885122 B2 JP 4885122B2
- Authority
- JP
- Japan
- Prior art keywords
- protein
- injury
- sample
- marker
- map
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/11—Automated chemical analysis
- Y10T436/117497—Automated chemical analysis with a continuously flowing sample or carrier stream
- Y10T436/118339—Automated chemical analysis with a continuously flowing sample or carrier stream with formation of a segmented stream
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56281904P | 2004-04-15 | 2004-04-15 | |
US60/562,819 | 2004-04-15 | ||
PCT/US2005/013045 WO2005113798A2 (en) | 2004-04-15 | 2005-04-15 | Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2007535318A JP2007535318A (ja) | 2007-12-06 |
JP2007535318A5 JP2007535318A5 (US07456027-20081125-C00001.png) | 2008-06-05 |
JP4885122B2 true JP4885122B2 (ja) | 2012-02-29 |
Family
ID=35428934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007508611A Expired - Fee Related JP4885122B2 (ja) | 2004-04-15 | 2005-04-15 | 癌、器官傷害、および筋肉リハビリテーション/運動過剰訓練についての診断の生物マーカーとしてのタンパク質分解マーカー |
Country Status (8)
Families Citing this family (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2207033B1 (en) * | 2004-04-15 | 2014-06-18 | University of Florida Research Foundation, Inc. | Neural proteins as biomarkers for nervous system injury and other neural disorders |
US8492107B2 (en) | 2004-04-15 | 2013-07-23 | University Of Florida Research Foundation, Inc. | Neural proteins as biomarkers for nervous system injury and other neural disorders |
US7883858B2 (en) * | 2005-01-27 | 2011-02-08 | Institute For Systems Biology | Methods for identifying and monitoring drug side effects |
ES2732071T3 (es) * | 2005-04-01 | 2019-11-20 | Univ Florida | Biomarcadores de lesiones hepáticas |
US8048638B2 (en) * | 2005-04-01 | 2011-11-01 | University Of Florida Research Foundation, Inc. | Biomarkers of liver injury |
CA2636990A1 (en) * | 2006-01-13 | 2007-07-26 | Battelle Memorial Institute | Animal model for assessing copd-related diseases |
EP1840574A1 (en) | 2006-03-30 | 2007-10-03 | Institut Pasteur | Use of the alpha chain of brain spectrin and fragments thereof, for diagnosing cerebral diseases |
WO2007140972A1 (en) * | 2006-06-06 | 2007-12-13 | F. Hoffmann-La Roche Ag | Transgelin-3 as biomarker for alzheimer's disease |
WO2008079407A1 (en) * | 2006-12-26 | 2008-07-03 | Brigham Young University | Serum proteomics system and associated methods |
IL199534A (en) | 2007-01-05 | 2013-01-31 | Univ Zuerich | An isolated human antibody capable of detecting a neoepitope in a disease-related protein, a polynucleotide encoding an antibody, a vector containing the polynucleotide, a host cell containing the polynucleotide or vector, a preparation containing the antibody and related methods and uses. |
WO2008097618A1 (en) * | 2007-02-06 | 2008-08-14 | University Of Florida Research Foundation, Inc. | Synaptotagmin and collapsin response mediator protein as biomarkers for traumatic brain injury |
EP2155259A2 (en) * | 2007-05-10 | 2010-02-24 | The Trustees of Columbia University in the City of New York | Methods for diagnosing diseases and evaluating treatments therefor using pet |
US9000134B2 (en) * | 2007-05-11 | 2015-04-07 | Wallace B. Haigh | Reagent and kit for early diagnosis of kidney disease |
AU2013200258B2 (en) * | 2007-09-13 | 2016-06-09 | Peptcell Limited | Peptide sequences and compositions |
WO2009048597A1 (en) * | 2007-10-10 | 2009-04-16 | Tenera Technology, Llc | Measurement of protease activity in post-mortem meat samples |
GB2453589A (en) | 2007-10-12 | 2009-04-15 | King S College London | Protease inhibition |
EP2105742A1 (en) * | 2008-03-26 | 2009-09-30 | Sanofi-Aventis | Use of cathepsin C |
EP4235181A3 (en) * | 2008-08-11 | 2024-02-28 | Banyan Biomarkers Inc | Biomarker detection process and assay of neurological condition |
US10359425B2 (en) | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
WO2010030697A1 (en) * | 2008-09-09 | 2010-03-18 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
US20100221752A2 (en) * | 2008-10-06 | 2010-09-02 | Somalogic, Inc. | Ovarian Cancer Biomarkers and Uses Thereof |
IT1392238B1 (it) * | 2008-12-02 | 2012-02-22 | Fond Santa Lucia | Uso della caspasi-3 per la malattia dell'alzheimer |
US7952068B2 (en) | 2008-12-16 | 2011-05-31 | Quest Diagnostics Investments Incorporated | Methods for detecting catecholamines by mass spectrometry |
EP2293072A1 (en) * | 2009-08-31 | 2011-03-09 | Sanofi-Aventis | Use of cathepsin H |
JP5909447B2 (ja) | 2009-09-14 | 2016-04-26 | バンヤン・バイオマーカーズ・インコーポレーテッド | ニューロン損傷診断のためのマイクロrna、自己抗体およびタンパク質マーカー |
EP2531224B1 (en) | 2010-01-26 | 2019-06-05 | Bioregency, Inc. | Compositions and methods relating to argininosuccinate synthetase |
AU2011229918B2 (en) * | 2010-03-24 | 2015-02-05 | Parker Proteomics, Llc | Methods for conducting genetic analysis using protein polymorphisms |
AU2011235892B2 (en) * | 2010-04-01 | 2016-07-07 | Banyan Biomarkers, Inc. | Markers and assays for detection of neurotoxicity |
WO2011160096A2 (en) * | 2010-06-17 | 2011-12-22 | Banyan Biomarkers, Inc. | Glial fibrillary acidic protein, autoantigens and autoantibodies thereto as biomarkers of neural injury or neurological disorder or condition |
US20130116150A1 (en) | 2010-07-09 | 2013-05-09 | Somalogic, Inc. | Lung Cancer Biomarkers and Uses Thereof |
SG2014007454A (en) | 2010-08-13 | 2014-07-30 | Somalogic Inc | Pancreatic cancer biomarkers and uses thereof |
WO2012051519A2 (en) | 2010-10-14 | 2012-04-19 | The Johns Hopkins University | Biomarkers of brain injury |
US9891232B2 (en) | 2010-11-09 | 2018-02-13 | Sarcotein Diagnostics, Llc | BIN1 expression as a marker of skeletal muscle mass and neurological conditions |
US9612306B2 (en) * | 2010-11-26 | 2017-04-04 | Brigham And Women's Hospital, Inc. | Method for assessing repetitive head injuries with two-dimensional magnetic resonance spectroscopy |
KR101333207B1 (ko) * | 2011-07-13 | 2013-11-26 | 부산대학교 산학협력단 | 자궁내막증과 연관된 유전자 마커 및 이의 용도 |
CA2850178C (en) | 2011-09-30 | 2020-02-25 | Sarcotein Diagnostics, Llc | Bin1 expression as a marker of cancer |
US8604016B2 (en) | 2011-11-21 | 2013-12-10 | Calithera Biosciences Inc. | Heterocyclic inhibitors of glutaminase |
WO2013138509A1 (en) | 2012-03-13 | 2013-09-19 | The Johns Hopkins University | Citrullinated brain and neurological proteins as biomarkers of brain injury or neurodegeneration |
US20140024053A1 (en) * | 2012-07-20 | 2014-01-23 | Banyan Biomarkers, Inc. | Methods, kits and devices for detecting bii-spectrin, and breakdown products thereof, as biomarkers for the diagnosis of neural injury |
BR112015003326A2 (pt) | 2012-08-16 | 2017-07-04 | Ipierian Inc | métodos de tratamento de uma tauopatia |
PT2920168T (pt) | 2012-11-16 | 2021-10-18 | Calithera Biosciences Inc | Inibidores heterocíclicos de glutaminase |
KR20150091389A (ko) * | 2012-12-03 | 2015-08-10 | 칼리테라 바이오사이언시즈 인코포레이티드 | 글루타미나제의 헤테로사이클릭 억제제에 의한 암 치료 |
US9265458B2 (en) | 2012-12-04 | 2016-02-23 | Sync-Think, Inc. | Application of smooth pursuit cognitive testing paradigms to clinical drug development |
DE102012223378A1 (de) * | 2012-12-17 | 2014-06-18 | Charité - Universitätsmedizin Berlin | In-vitro Verfahren und Kit zur Diagnose von akutem Koronarsyndrom |
US8980270B2 (en) | 2013-01-18 | 2015-03-17 | Ipierian, Inc. | Methods of treating a tauopathy |
US10235339B2 (en) | 2013-02-19 | 2019-03-19 | Keysight Technologies, Inc. | Digital measurement instrument triggered by signal pattern |
US9380976B2 (en) | 2013-03-11 | 2016-07-05 | Sync-Think, Inc. | Optical neuroinformatics |
US10534003B2 (en) | 2013-07-17 | 2020-01-14 | The Johns Hopkins University | Multi-protein biomarker assay for brain injury detection and outcome |
JP2017512751A (ja) | 2014-02-14 | 2017-05-25 | アイピエリアン,インコーポレイティド | タウペプチド、抗タウ抗体、およびそれらの使用方法 |
WO2015192014A1 (en) | 2014-06-13 | 2015-12-17 | Calithera Biosciences, Inc. | Combination therapy with glutaminase inhibitors |
WO2015191825A1 (en) * | 2014-06-13 | 2015-12-17 | Biogen Ma Inc. | Methods for the detection and measurement of amyloid beta in biological samples |
AU2015300825B2 (en) | 2014-08-07 | 2019-10-10 | Calithera Biosciences, Inc. | Crystal forms of glutaminase inhibitors |
KR102328327B1 (ko) | 2014-09-26 | 2021-11-22 | 소마로직, 인크. | 심혈관 위험 사건 예측 및 이의 용도 |
US20170335395A1 (en) * | 2014-10-27 | 2017-11-23 | The Trustees Of The University Of Pennsylvania | A parkinson's disease diagnostic biomarker panel |
MA41115A (fr) | 2014-12-02 | 2017-10-10 | Biogen Int Neuroscience Gmbh | Procédé de traitement de la maladie d'alzheimer |
EP3265811B1 (en) | 2015-03-02 | 2022-10-26 | Sarcotein Diagnostics LLC | 13+/17+ bin1 expression as a marker of cardiac disorders |
SG11201708153XA (en) | 2015-04-06 | 2017-11-29 | Calithera Biosciences Inc | Treatment of lung cancer with inhibitors of glutaminase |
WO2017027685A2 (en) * | 2015-08-13 | 2017-02-16 | New York University | Antibody-based molecules specific for the truncated asp421 epitope of tau and their uses in the diagnosis and treatment of tauopathy |
CN108601767A (zh) | 2015-10-05 | 2018-09-28 | 卡利泰拉生物科技公司 | 用谷氨酰胺酶抑制剂和免疫肿瘤学药剂的组合疗法 |
EP3387430A4 (en) * | 2015-12-11 | 2019-08-14 | Expression Pathology, Inc. | SRM / MRM DOSINGS |
EP3452828A4 (en) * | 2016-05-06 | 2019-12-04 | Nanosomix Inc. | BIOMARKERS OF SYNAPTIC PROTEINS AND DIFFERENTIAL DIAGNOSIS OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS |
SG11201901389XA (en) | 2016-08-25 | 2019-03-28 | Calithera Biosciences Inc | Combination therapy with glutaminase inhibitors |
EP3503893A4 (en) | 2016-08-25 | 2020-04-29 | Calithera Biosciences, Inc. | COMBINATION THERAPY WITH GLUTAMINE INHIBITORS |
CN110520440A (zh) | 2017-02-17 | 2019-11-29 | 戴纳立制药公司 | 抗τ抗体及其使用方法 |
US11016092B2 (en) | 2017-03-23 | 2021-05-25 | Abbott Laboratories | Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase L1 |
WO2018191531A1 (en) | 2017-04-15 | 2018-10-18 | Abbott Laboratories | Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers |
BR112019022476A2 (pt) | 2017-04-28 | 2020-05-12 | Abbott Laboratories | Métodos para o auxílio no diagnóstico e determinação hiperagudos de lesão cerebral traumática usando biomarcadores iniciais em pelo menos duas amostras a partir do mesmo ser humano |
CA3078725A1 (en) | 2017-05-25 | 2018-11-29 | Abbott Laboratories | Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers |
BR112019025313A2 (pt) | 2017-05-30 | 2020-06-23 | Abbott Laboratories | Métodos para auxílio no diagnóstico e avaliação de uma lesão cerebral traumática leve em um indivíduo humano usando troponina cardíaca i |
EP3649474A1 (en) | 2017-07-03 | 2020-05-13 | Abbott Laboratories | Improved methods for measuring ubiquitin carboxy-terminal hydrolase l1 levels in blood |
WO2019018545A1 (en) | 2017-07-18 | 2019-01-24 | The Research Foundation For The State University Of New York | BIOMARKERS OF INTRACRANIAL ANEVISM |
RU2668534C1 (ru) * | 2017-07-18 | 2018-10-01 | Общество с ограниченной ответственностью "ДРД" | Диагностический набор реагентов для выявления хронических патологий мозга ишемического генеза |
EA202090555A1 (ru) | 2017-08-22 | 2020-06-08 | Байоджен Ма Инк. | Фармацевтические композиции, содержащие антитела к бета-амилоиду |
CN107976481B (zh) * | 2017-11-01 | 2020-04-07 | 广西壮族自治区食品药品检验所 | 一种中药材中钪含量的检测方法 |
US11016105B2 (en) | 2017-12-09 | 2021-05-25 | Abbott Laboratories | Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of GFAP and UCH-L1 |
EP3721233A2 (en) | 2017-12-09 | 2020-10-14 | Abbott Laboratories | Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (tbi), using glial fibrillary acidic protein (gfap) and/or ubiquitin carboxy-terminal hydrolase l1 (uch-l1) |
EP4065986A4 (en) * | 2019-11-26 | 2023-11-15 | Ohio State Innovation Foundation | METHODS AND COMPOSITIONS FOR DETECTING AND MANAGING CARDIOVASCULAR DISEASES |
CN112661828B (zh) * | 2021-01-15 | 2022-04-01 | 武汉大学 | 一种突触素的抗原肽及其抗体与应用 |
BR102021020613A2 (pt) * | 2021-10-14 | 2023-04-18 | Universidade Federal Do Rio De Janeiro | Método de investigação proteômica em amostra para diagnóstico da rabdomiólise e kits para realização do mesmo |
US11928221B2 (en) | 2021-11-29 | 2024-03-12 | Bank Of America Corporation | Source code clustering for automatically identifying false positives generated through static application security testing |
US11941115B2 (en) | 2021-11-29 | 2024-03-26 | Bank Of America Corporation | Automatic vulnerability detection based on clustering of applications with similar structures and data flows |
CN116297952B (zh) * | 2023-03-10 | 2023-10-31 | 山东省食品药品检验研究院 | 一种基于肽组学的用于海马物种鉴别的肽生物标志物及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998003190A1 (en) * | 1996-07-19 | 1998-01-29 | Neurotrauma Therapeutics, Inc. | Calpain inhibitors for the treatment of traumatic brain injury |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5118606A (en) | 1988-09-02 | 1992-06-02 | The Regents Of The University Of California | Methods for detecting cellular pathology by assaying spectrin and spectrin breakdown products |
US5912121A (en) * | 1992-12-11 | 1999-06-15 | Bringham And Women's Hospital | Methods for detecting mutations associated with hypertrophic cardiomyopathy |
US5536639A (en) | 1994-03-25 | 1996-07-16 | Cephalon, Inc. | Methods for detecting calpain activation by detection of calpain activated spectrin breakdown products |
US6048703A (en) | 1996-11-15 | 2000-04-11 | Cephalon, Inc. | Methods for detecting cell apoptosis |
US7384751B1 (en) * | 1997-07-16 | 2008-06-10 | Queen's University At Kingston | Methods of diagnosing muscle damage |
EP1137668A1 (en) | 1998-12-09 | 2001-10-04 | Frank P. Zemlan | A method for detecting neuronal cell damage by quantification of map-2 levels in biological fluids |
US6589746B1 (en) | 1999-10-21 | 2003-07-08 | University Of Cincinnati | Method of detecting axonally-derived protein tau in patients with traumatic CNS injury |
US6819325B2 (en) * | 2000-03-07 | 2004-11-16 | Microsoft Corporation | API communications for vertex and pixel shaders |
US20030040660A1 (en) | 2001-08-27 | 2003-02-27 | George Jackowski | Method for diagnosing and distinguishing traumatic brain injury and diagnostic devices for use therein |
WO2004025298A1 (en) * | 2002-09-11 | 2004-03-25 | University Of Florida | Analyzing nerve cell damage |
US7196169B2 (en) * | 2002-10-11 | 2007-03-27 | Queen's University At Kingston | Isolated post-translationally modified mammalian proteins for monitoring and diagnosing muscle damage |
DE602004022645D1 (de) * | 2003-03-31 | 2009-10-01 | Univ Florida | Beurteilung von nervenschäden anhand von blutproben |
US20050202508A1 (en) * | 2003-11-12 | 2005-09-15 | Pasinetti Guilio M. | Biomarker for Parkinson's disease |
EP2207033B1 (en) | 2004-04-15 | 2014-06-18 | University of Florida Research Foundation, Inc. | Neural proteins as biomarkers for nervous system injury and other neural disorders |
ES2732071T3 (es) | 2005-04-01 | 2019-11-20 | Univ Florida | Biomarcadores de lesiones hepáticas |
US7398484B2 (en) * | 2005-04-27 | 2008-07-08 | Microsoft Corporation | Memory efficient array transposition via multi pass tiling |
-
2005
- 2005-04-15 ES ES05779948T patent/ES2367311T3/es active Active
- 2005-04-15 AU AU2005245785A patent/AU2005245785B2/en not_active Ceased
- 2005-04-15 AT AT05779948T patent/ATE512365T1/de not_active IP Right Cessation
- 2005-04-15 JP JP2007508611A patent/JP4885122B2/ja not_active Expired - Fee Related
- 2005-04-15 CA CA2578680A patent/CA2578680C/en active Active
- 2005-04-15 WO PCT/US2005/013045 patent/WO2005113798A2/en active Application Filing
- 2005-04-15 EP EP05779948A patent/EP1747282B1/en active Active
- 2005-04-15 US US11/106,932 patent/US7456027B2/en active Active
-
2008
- 2008-06-11 US US12/137,156 patent/US8298835B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998003190A1 (en) * | 1996-07-19 | 1998-01-29 | Neurotrauma Therapeutics, Inc. | Calpain inhibitors for the treatment of traumatic brain injury |
Also Published As
Publication number | Publication date |
---|---|
AU2005245785A2 (en) | 2005-12-01 |
US7456027B2 (en) | 2008-11-25 |
WO2005113798A3 (en) | 2008-10-23 |
EP1747282A4 (en) | 2009-11-11 |
ES2367311T3 (es) | 2011-11-02 |
WO2005113798A2 (en) | 2005-12-01 |
ATE512365T1 (de) | 2011-06-15 |
JP2007535318A (ja) | 2007-12-06 |
AU2005245785A1 (en) | 2005-12-01 |
AU2005245785B2 (en) | 2011-04-07 |
EP1747282B1 (en) | 2011-06-08 |
US20050260697A1 (en) | 2005-11-24 |
CA2578680C (en) | 2011-06-14 |
US20090317805A1 (en) | 2009-12-24 |
CA2578680A1 (en) | 2005-12-01 |
US8298835B2 (en) | 2012-10-30 |
EP1747282A2 (en) | 2007-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4885122B2 (ja) | 癌、器官傷害、および筋肉リハビリテーション/運動過剰訓練についての診断の生物マーカーとしてのタンパク質分解マーカー | |
US20220113321A1 (en) | Neural proteins as biomarkers for nervous system injury and other neural disorders | |
JP4659025B2 (ja) | 神経系傷害および他の神経障害についての生物マーカーとしての神経タンパク質 | |
US20140303041A1 (en) | In vitro diagnostic devices for nervous system injury and other neural disorders | |
JP4757266B2 (ja) | バイオマーカー及びその使用 | |
EP3835424A1 (en) | Diagnostic drug and diagnostic method for alzheimer's disease | |
US10745736B2 (en) | Markers for mood disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080414 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080414 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101117 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110215 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110222 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110512 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110811 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111027 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20111124 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20111207 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20141216 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4885122 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |